Paeds SAQs · paediatric-dermatology
Congenital melanocytic naevi and pigmentary birthmarks — formative SAQs
Formative SAQs on the congenital pigmentary birthmarks: applying the size-based classification and the risk stratification of the congenital melanocytic naevus, recognising the neurocutaneous-melanocytosis risk pattern, and counselling the family on the surveillance and the management.
On this page
Study tools
Target exams
SAQ 1 (10 marks) — The six-week-old with a large dark birthmark on the back
Stem: A six-week-old girl is brought by her mother, who has noticed a large dark-brown patch covering most of the upper back since birth. The patch is well-defined, slightly raised, and covered with fine dark hair, and there are about a dozen smaller dark-brown spots scattered over the rest of the back and the shoulders. She was born at term, she is feeding and growing well, and her development is on track. On examination, the patch measures fourteen by sixteen centimetres over the thoracic spine, with the surrounding satellite nevi. The head circumference is on the fiftieth centile, the fontanelle is soft, and the neurological examination is normal. Outline your assessment, your diagnosis, and your management plan. [2] [6]
Model answer
Assessment and diagnosis (3 marks). This is a large congenital melanocytic naevus on the posterior axis with multiple satellite nevi. The lesion is a congenital melanocytic naevus on the morphological features — the brown colour, the well-defined border, the raised and the hairy surface, and the presence at the birth. The classification is by the projected adult size, and a fourteen-by-sixteen-centimetre lesion over the back, where the projected adult size is larger than the size in infancy, falls into the large category (projected adult size 20 cm and over). The dozen satellite nevi define the CMN syndrome pattern. The posterior-axis location (the thoracic spine) with the multiple satellites is the high-risk pattern for the neurocutaneous melanocytosis. [2] [1]
Risk stratification (3 marks). The melanoma risk in the CMN tracks the size, and the large and the giant CMN carry the elevated risk that is concentrated in the childhood and the adolescence, while the small and the medium CMN carry a risk close to the population risk. The neurocutaneous-melanocytosis risk is concentrated in the large or the giant posterior-axis CMN with the multiple satellites, so this child is in the group that warrants the consideration of the CNS imaging. The child is currently well, with a normal head circumference and neurology, which argues against the symptomatic neurocutaneous melanocytosis at the present. [1] [6]
Management (3 marks). The management is the referral to the specialist CMN service for the multidisciplinary assessment. The assessment includes the baseline photography and the dermoscopy, the consideration of the MRI of the brain and the spine for the neurocutaneous-melanocytosis screening (the high-risk pattern), and the establishment of the surveillance. The surgery and the laser are the individualised options for the cosmetic, the functional, or the difficult-to-monitor indication, not the routine prophylactic excision, because the prophylactic excision does not eliminate the melanoma risk. The family is counselled on the risk, the surveillance, the sun protection, and the change that must prompt the review. [3] [6]
Counselling and follow-up (1 mark). The family is counselled that the melanoma risk is elevated but not certain, that the surveillance is the early detection, and that the lesion will be monitored with the photography and the skin checks. The psychosocial support — the cosmetic burden, the anxiety, and the peer linkage — is the integral element. The safety-net is the change in the lesion, or the development of the headache, the seizure, or the developmental regression, that must prompt the urgent review. [3] [10]
References7ShowHide
- [1]Krengel S, Reyes-Múgica M. Melanoma risk in congenital melanocytic naevi. British Journal of Dermatology, 2017.PMID 28504374
- [2]Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. Journal of the American Academy of Dermatology, 2013.PMID 22982004
- [3]Krengel S, Marghoob AA. Current management approaches for congenital melanocytic nevi. Dermatologic Clinics, 2012.PMID 22800546
- [6]Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. Journal of Investigative Dermatology, 2013.PMID 23392294
- [10]Dohil MA, Baugh WP, Eichenfield LF. Vascular and pigmented birthmarks. Pediatric Clinics of North America, 2000.PMID 10943257
- [7]Caccavale S, Calabrese G, Mattiello E, et al. Cutaneous Melanoma Arising in Congenital Melanocytic Nevus: A Retrospective Observational Study. Dermatology, 2021.PMID 33053549
- [11]Tey HL. A practical classification of childhood hypopigmentation disorders. Acta Dermato-Venereologica, 2010.PMID 20107718